Salient Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 36900709
Naverland 22, 2600 Glostrup
us@salientpharma.com
tel: 42806300
www.salientpharma.com

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
Gross profit- 729.82- 484.92- 261.31- 125.51- 233.31
Employee benefit expenses- 596.75- 402.94
EBIT-1 326.57- 887.87- 261.31- 125.51- 233.31
Other financial expenses-4.94-13.73-39.95-62.65-71.62
Reduction non-current investment assets- 315.04
Pre-tax profit-1 646.56- 901.59- 301.26- 188.16- 304.93
Income taxes- 713.28
Net earnings-2 359.83- 901.59- 301.26- 188.16- 304.93

Assets (kDKK)

20192020202120222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Finished products/goods12.1611.46
Inventories total12.1611.46
Current trade debtors3.46
Prepayments and accrued income6.14
Current other receivables144.3032.7417.8117.5912.28
Short term receivables total150.4432.7417.8117.5915.73
Cash and bank deposits428.4612.4824.9328.964.89
Cash and cash equivalents428.4612.4824.9328.964.89
Balance sheet total (assets)578.9045.2254.9058.0120.62

Equity and liabilities (kDKK)

20192020202120222023
Share capital57.1257.1257.1257.12182.66
Retained earnings2 712.37352.53- 549.06- 850.32-1 038.48
Profit of the financial year-2 359.83- 901.59- 301.26- 188.16- 304.93
Shareholders equity total409.65- 491.95- 793.20- 981.37-1 160.74
Non-current deferred tax liabilities32.04
Non-current liabilities total32.04
Current trade creditors64.24113.90162.55147.02217.62
Current owed to participating341.67680.09892.36963.74
Other non-interest bearing current liabilities72.9781.605.46
Current liabilities total137.22537.16848.101 039.371 181.37
Balance sheet total (liabilities)578.9045.2254.9058.0120.62
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.